Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2022
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
Benoit You, Christopher Purdy, Larry J Copeland, et al.
Gynecologic Oncology
|
February 1, 2011
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations
Robin A Lacour, Shannon N Westin, Larissa A Meyer, et al.
Gynecologic Oncology
|
February 5, 2021
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
Kimberly K Leslie, Virginia L Filiaci, Adrianne R Mallen, et al.
The Journal of Clinical Investigation
|
May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rebecca Drexler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2026
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo)
Joshua P Schiff, Silpa Raju-Salicki, Tyler R McKinnish, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rikki Drexler, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
January 19, 2019
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla, Jonathan S Berek, Mauricio Cuello Fredes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2024
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
Daniela E Matei, Danielle M Enserro, Marcus E Randall, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2010
Cervical cancer
Benjamin E Greer, Wui-Jin Koh, Nadeem R Abu-Rustum, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2022
Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
Benoit You, Christopher Purdy, Larry J Copeland, et al.
Gynecologic Oncology
|
February 1, 2011
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations
Robin A Lacour, Shannon N Westin, Larissa A Meyer, et al.
Gynecologic Oncology
|
February 5, 2021
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
Kimberly K Leslie, Virginia L Filiaci, Adrianne R Mallen, et al.
The Journal of Clinical Investigation
|
May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rebecca Drexler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 23, 2026
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo)
Joshua P Schiff, Silpa Raju-Salicki, Tyler R McKinnish, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Angela Schab, Amanda Compadre, Rikki Drexler, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
January 19, 2019
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla, Jonathan S Berek, Mauricio Cuello Fredes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2015
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J Goodfellow, Caroline C Billingsley, Heather A Lankes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2024
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
Daniela E Matei, Danielle M Enserro, Marcus E Randall, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 15, 2010
Cervical cancer
Benjamin E Greer, Wui-Jin Koh, Nadeem R Abu-Rustum, et al.
Page
of 9